Literature DB >> 8505206

A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.

G M Grass1, V H Lee.   

Abstract

PURPOSE: To develop methods for constructing a pharmacokinetic model to predict the time course of aqueous humor and plasma drug concentrations after topical dosage in rabbits using the simulation program iThink (formerly STELLA; High Performance Systems, Lyme, NH).
METHOD: The model was constructed in experimentally verifiable segments using previously published data on intravenous, nasal, and ocular dosage, and was used to describe the influence of prolonging precorneal retention and varying drug release rate on the ratio of drug absorbed locally to drug absorbed systemically in rabbits.
RESULTS: The model developed is comprehensive; it includes precorneal kinetics, nasal absorption kinetics, and plasma kinetics.
CONCLUSIONS: Such a model may be useful in designing drug delivery strategies to improve the safety of topical eye medications through minimization of systemic absorption and maximization of drug delivery to ocular tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505206

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.

Authors:  Maxime Le Merdy; Jianghong Fan; Michael B Bolger; Viera Lukacova; Jessica Spires; Eleftheria Tsakalozou; Vikram Patel; Lin Xu; Sharron Stewart; Ashok Chockalingam; Suresh Narayanasamy; Rodney Rouse; Murali Matta; Andrew Babiskin; Darby Kozak; Stephanie Choi; Lei Zhang; Robert Lionberger; Liang Zhao
Journal:  AAPS J       Date:  2019-05-20       Impact factor: 4.009

Review 2.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

3.  LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.

Authors:  Tanya T Khan; Guorong Li; Iris D Navarro; Rama D Kastury; Carol J Zeil; Taras M Semchyshyn; Frank J Moya; David L Epstein; Pedro Gonzalez; Pratap Challa
Journal:  Mol Vis       Date:  2010-11-02       Impact factor: 2.367

4.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

5.  A STELLA simulation model for in vitro dissolution testing of respirable size particles.

Authors:  Basanth Babu Eedara; Ian G Tucker; Shyamal C Das
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

6.  Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.

Authors:  Maxime Le Merdy; Jessica Spires; Viera Lukacova; Ming-Liang Tan; Andrew Babiskin; Xiaoming Xu; Liang Zhao; Michael B Bolger
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.